Recurrent Oropharyngeal Squamous Cell Carcinomas Maintain Anti-tumor Immunity and Multinucleation Levels Following Completion of Radiation
Year: 2023
Type: article
Study design: Observational Study
Source: Head and Neck Pathology
Institutions: Baylor College of Medicine, Georgia Institute of Technology, Emory University, The Wallace H. Coulter Department of Biomedical Engineering, Louis Stokes Cleveland VA Medical Center, Michael E. DeBakey VA Medical Center, Vanderbilt University, Vanderbilt University Medical Center, Veterans Health Administration
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: U.S. Department of Veterans Affairs, National Institutes of Health, Clinical and Translational Science Collaborative of Cleveland, School of Medicine, Case Western Reserve University, National Cancer Institute, National Center for Research Resources, National Center for Advancing Translational Sciences
Awards: RadxTools for assessing tumor treatment response on imaging, Lung cancer in East Africa and the relationship to HIV-1 infection: epidemiology, molecular characterization and imaging, Pathology Image Informatics Platform for visualization, analysis and management, A Study to Validate and Improve an Automated Image Analysis Algorithm to Detect Tuberculosis in Sputum Smear Slides, BIOMEDICAL ENGINEERING RESEARCH FACILITIES, CHIRP Computerized Histologic Risk Predictor (CHiRP) for Early Stage Lung Cancers, G4862376799, HistoTools: A suite of digital pathology tools for quality control, annotation and dataset identification, MR Fingerprinting and Computerized Decision Support for Prostate Cancer, Computerized histologic image predictor of cancer outcome, Quantitative Histomorphometric Risk Classifier (QuHbIC) in HPV + Oropharyngeal Carcinoma, Clinical and Translational Science Collaborative of Cleveland, Clinical and Translational Science Collaborative of Northern Ohio, Catalyzing Linkages for Everyone's Health (CLE Health), Novel Radiomics for Predicting Response to Immunotherapy for Lung Cancer, Oral Cavity Quantitative Histomorphometric Risk Classifier (OHbIC) in Oral Cavity Squamous Cell Carcinoma (OC-SCC), Baylor College of Medicine Cancer Center - Cancer Center Support Grant, Mayo Clinic Breast Cancer SPORE
OpenAlex ID: W4388932176